Serotonin Mechanisms in Pain and Functional Syndromes

References

• Lipton R B, Stewart W F, Diamond S, Diamond M L, Reed M. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache 2001; 41: 646–57
   PubMed Web of Science ®Google Scholar
• Barbanti P. Migraine. Cephalgia 2001; 21: 295
   Google Scholar
• Kanieki R. Migraine. Neurology 2002; Vol(Suppl 6)S15–S20
   Google Scholar
• Eisensamer B, Rammes G, Gimpl G, et al. Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Mol Psychiatry 2003; 8: 994–1007
   PubMed Web of Science ®Google Scholar
• Sechi L A, Tedde R, Cassisa L, Pala A, Marigliano A, Masia S, Melis A. Evidence for a direct and non-receptor-mediated action of 5HT2 antagonists on transmembrane cation transport systems. Cardiovasc Drugs Ther 1990; 4(Suppl 1)63–7
   Google Scholar
• Gillin J C, Salin-Pascual R, Velazquez-Moctezuma J, et al. Cholinergic receptor subtypes and REM sleep in animals and normal controls. Prog Brain Res 1993; 98: 379–87
   Google Scholar
• Drossman D A, Thompson W G. Irritable bowel syndrome: A graduated multicomponent treatment approach. Ann Int Med 1992; 116: 1009–16
   PubMed Web of Science ®Google Scholar
• Lydiard R B, Fossey M D, Marsh W, Ballenger J C. Prevalence of psychiatric disorders in patients with irritable bowel syndrome. Psychosomatics 1993; 34: 229–234
   PubMed Web of Science ®Google Scholar
• Walker E A, et al. Comorbidity of gastrointestinal complaints, depression and anxiety in the epidemiological catchment area (ECA) study. Am J Med 1993; 92(Suppl 1A)26–30
   Google Scholar
• Mayou R, Bryant B, Forfar C, Clark D. Non-cardiac chest pain and benign palpitations in the cardiac clinic. Br Heart J 1994; 72: 548–53
   PubMedGoogle Scholar
• Siriwardena A, Booker C, Pratt J, Kellum J M. Pathways of serotonin-induced electrolyte transport in rat distal colon. Surgery 1995; 110(2)411–7, discussion 417–8
   Google Scholar
• Thor K B, Katofiasc M A. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat. J Pharmacol Exp Ther 1995; 274(2)1014–24
   PubMed Web of Science ®Google Scholar
• Engel G, Hoyer D, Kalkman H O, Wick M B. Identification of 5HT2-receptors on longitudinal muscle of the guinea pig ileum. J Recept Res 1984; 4(1–6)113–26
   PubMed Web of Science ®Google Scholar
• Rudnick A, Modai I, Zelikovski A. Fluoxetine-induced Raynaud's phenomenon. Biol Psychiatry 1997; 41: 1218–21
   Google Scholar
• Kumagai S, Morinobu A, Ozaki S, Nakao K, Ishida H. Sarpogrelate hydrochloride for Raynaud's phenomenon of patients with collagen diseases. Ryumachi 1998; 38(3)504–10
   Google Scholar
• Sarchielli P, Alberti A, Russo S, et al. Nitric oxide pathway, Ca2+, and serotonin content in platelets from patients suffering from chronic daily headache. Cephalalgia 1999; 19: 810–16
   PubMedGoogle Scholar
• Goadsby P J, Lance J W. Physiopathology of migraine. Rev Prat Feb. 11, 1990; 40(5)389–93
   Google Scholar
• Lance J W. Fifty years ofmigraine research. Aust NZJ Med 1988; 18(3)311–7
   Google Scholar
• Srikiatkhachorn A, Anthony M. Serotonin receptor adaptation in patients with analgesic-induced headache. Cephalgia 1996; 419–22, 6
   Google Scholar
• Ghaemi S N. Recognizing bipolar disease in a unipolar world. Primary Psychiatry 2001; 8(2)28–34
   Google Scholar
• Manning J S, et al. The bipolar spectrum. Current Psychiatry 2003; 2(Suppl 3)6–9
   Google Scholar
• Manning J S, Connor P D, Sahai A. The bipolar spectrum: A review of current concepts and implications for the management of depression in primary care. Arch Fam Med 1998; 7: 63–71
   PubMedGoogle Scholar
• Strakowski S M, Del Bello M P, Adler C M. Comparative efficacy and tolerability of drug treatments for bipolar disorder. CNS Drugs. 2002; 15: 701–8
   Web of Science ®Google Scholar
• Jones B, Basson B R, Walker D J, et al. Weight change and atypical antipsychotic treatment in patients with schizophrenia. J Clin Psychiatry 2001; 62(Suppl 2)41–4
   PubMed Web of Science ®Google Scholar
• Nasrallah H. A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology 2003; 28: 83–96
   PubMed Web of Science ®Google Scholar
• Keck P E, McElroy S L, Strakowski S M. Anticonvulsants and antipsychotics in the treatment of bipolar disorder. J Clin Psychiatry 1998; 59(Suppl 6)74–81
   PubMedGoogle Scholar
• Calabrese J R, Bowden C L, Sachs G S, et al. A double-blind placebo controlled prophylaxis study of lamotrigene in rapid-cycling bipolar disorder. J Clin Psychiatry 2000; 61: 841–50
   PubMed Web of Science ®Google Scholar
• Solaro C, Ucalli M M, Ucalli A, et al. Low dose gabapentin combined with either lamotrigene or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. Eur Neurol 2000; 44: 45–8
   PubMed Web of Science ®Google Scholar
• Benedetti F, Colombo C, Pontiggia A, Bernasconi A, Florita M, Smeraldi E. Morning light treatment hastens the antidepressant effect of citalopram: A placebo-controlled trial. J Clin Psychiatry 2003; 64(6)648–53
   Google Scholar
• Shapiro D A, Renock S, Arrington E, et al. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 2003; 28(8)1400–11
   PubMed Web of Science ®Google Scholar
• Bourin M, Auby P, Marcus R N, et al. Aripiprazole versus haloperidol for maintained treatment effect in acute mania. Poster presented at the 156th APA Annual Meeting. San Francisco, California May 17–22, 2003
   Google Scholar
• Von Seggern R L, Mannix L K, Adelman J U. Rofecoxib in the prevention of perimenstrual migraine: An open-label pilot trial. Headache: The Journal of Head and Face Pain 2004; 44(2)165–6
   Google Scholar